Matches in Nanopublications for { ?s ?p "[Methylenetetrahydrofolate reductase A1298C and plasminogen activator inhibitor-1 4G variants recurred more frequently in HA patients with a less-severe phenotype.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 12 of
12
with 100 items per page.
- NP69384.RAJrLKG6BIgxU4AWxeBgCDCIQU3I9KXcv1UUNn3scl4Kg130_assertion description "[Methylenetetrahydrofolate reductase A1298C and plasminogen activator inhibitor-1 4G variants recurred more frequently in HA patients with a less-severe phenotype.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP69384.RAJrLKG6BIgxU4AWxeBgCDCIQU3I9KXcv1UUNn3scl4Kg130_provenance.
- NP415906.RA_Oeux9LdKquQStyIIN8ABzcyszsrQzN6k-Y-TATpfys130_assertion description "[Methylenetetrahydrofolate reductase A1298C and plasminogen activator inhibitor-1 4G variants recurred more frequently in HA patients with a less-severe phenotype.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP415906.RA_Oeux9LdKquQStyIIN8ABzcyszsrQzN6k-Y-TATpfys130_provenance.
- NP858775.RAbT3wDkz_SIXBWAuGwHfFmwwRMmnRi6kC21zSI4AmmVU130_assertion description "[Methylenetetrahydrofolate reductase A1298C and plasminogen activator inhibitor-1 4G variants recurred more frequently in HA patients with a less-severe phenotype.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP858775.RAbT3wDkz_SIXBWAuGwHfFmwwRMmnRi6kC21zSI4AmmVU130_provenance.
- assertion description "[Methylenetetrahydrofolate reductase A1298C and plasminogen activator inhibitor-1 4G variants recurred more frequently in HA patients with a less-severe phenotype.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[Methylenetetrahydrofolate reductase A1298C and plasminogen activator inhibitor-1 4G variants recurred more frequently in HA patients with a less-severe phenotype.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[Methylenetetrahydrofolate reductase A1298C and plasminogen activator inhibitor-1 4G variants recurred more frequently in HA patients with a less-severe phenotype.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP122730.RAWlY4vBaSSCh3POwSFnGbIyDK2kv3X_mKXRJn-b61iI0130_assertion description "[Methylenetetrahydrofolate reductase A1298C and plasminogen activator inhibitor-1 4G variants recurred more frequently in HA patients with a less-severe phenotype.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP122730.RAWlY4vBaSSCh3POwSFnGbIyDK2kv3X_mKXRJn-b61iI0130_provenance.
- NP91528.RAoUqE0jPMfL1ATBfq0_tNDU_K3kRoBSOh-LixyiNd08g130_assertion description "[Methylenetetrahydrofolate reductase A1298C and plasminogen activator inhibitor-1 4G variants recurred more frequently in HA patients with a less-severe phenotype.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP91528.RAoUqE0jPMfL1ATBfq0_tNDU_K3kRoBSOh-LixyiNd08g130_provenance.
- NP89284.RACvR9mBBjUwx8zk1347X5BvdW5grnnYvg2Nr9yY-4if0130_assertion description "[Methylenetetrahydrofolate reductase A1298C and plasminogen activator inhibitor-1 4G variants recurred more frequently in HA patients with a less-severe phenotype.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP89284.RACvR9mBBjUwx8zk1347X5BvdW5grnnYvg2Nr9yY-4if0130_provenance.
- NP606851.RAiWgFXzLCt_PlcV3iBDGuEYcFitHHN9ZEx2y_AWZeUYM130_assertion description "[Methylenetetrahydrofolate reductase A1298C and plasminogen activator inhibitor-1 4G variants recurred more frequently in HA patients with a less-severe phenotype.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP606851.RAiWgFXzLCt_PlcV3iBDGuEYcFitHHN9ZEx2y_AWZeUYM130_provenance.
- NP122729.RAp-Sq6YCJCP9nsLOwjQLLrUP56NWUQzFzB6TJahv19Mg130_assertion description "[Methylenetetrahydrofolate reductase A1298C and plasminogen activator inhibitor-1 4G variants recurred more frequently in HA patients with a less-severe phenotype.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP122729.RAp-Sq6YCJCP9nsLOwjQLLrUP56NWUQzFzB6TJahv19Mg130_provenance.
- NP669524.RAFtFNCmShRW3qcWBgrpXufLxgEt0Kj-p5tfqlsXbHouk130_assertion description "[Methylenetetrahydrofolate reductase A1298C and plasminogen activator inhibitor-1 4G variants recurred more frequently in HA patients with a less-severe phenotype.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP669524.RAFtFNCmShRW3qcWBgrpXufLxgEt0Kj-p5tfqlsXbHouk130_provenance.